The second ICPerMed Conference will take place from 15-16 October 2020 at the Maison de la Chimie in Paris, France.
ECRIN's celebration of International Clinical Trials Day (ICTD) will be held on May 27th, 2021 in Berlin (Langenbeck-Virchow-Haus Berlin, Luisenstraße 58/59, 10117 Berlin, Germany). The topic will be (patient-)recruitment in clinical trials. More details to come!
Registration is now closed for ECRIN's meeting on International Clinical Trials Day, to be held in Prague on May 20th. The theme of this year's event is "Clinical trials in the era of personalised medicine".
The 2016 celebration of International Clinical Trials Day aims to increase awareness of ECRIN and its Czech national scientific partner – Czech Clinical Research Infrastructure Network (CZECRIN) – among Czech policymakers and the scientific community, as well as to address issues related to personalised medicine and multinational clinical trials.
EFGCP Workshop & Discussion on How to Ensure Optimal Ethical Review within the New Clinical Trials Regulation
The European Forum for Good Clinical Practice (EFGCP) is hosting a workshop on April 13th in Brussels on how to ensure optimal ethical review within the context of new clinical trials regulation.
The context for this event is the adopation by European legislators of revised clinical trials regulation in 2014. The revised legal framework is expected to bring about significant advances and is expected to be fully implemented as soon as the supporting Clinical Trials Portal and Database are fully functional (2H2017).
The European Forum for Good Clinical Practice (EFGCP) is holding its 2016 annual conference on the topic of "Faster and Safer Paths to New Treatments: Bringing together the two worlds of pharmaceutical and device research to better serve public, patients and research participants". The event will take place from March 1st to 2nd, 2016 in Brussels, Belgium.
As part of the CORBEL project, ECRIN is hosting the first workshop of the patient-level data taskforce in Paris from March 3rd to 4th. The taskforce, which includes experts from various fields, will aim to reach a consensus on a common framework for providing access to patient-level clinical trial data. The creation of a database of anonymised, user-friendly patient data will be considered as a possible development.